Healthpoint
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Healthpoint sits in the top decile of US sponsors by registered trial count (#626 of 15,742 sponsors by registered trial count).
Healthpoint: 25 sponsored US clinical trials, none currently recruiting.
Healthpoint sponsors 25 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 22 completed. 11 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Follow up to Acute Wound Scar Study, with 1 trials.
Top-decile sponsor footprint
Healthpoint ranks in the top decile of sponsors by registered trial count (#626 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
22 of 25 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
25 total, page 1 of 1
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
NCT02154087
Santyl Applications to Diabetic Foot Ulcers
NCT02111291
Study of Oasis Ultra in Diabetic Foot Ulcers
NCT01835379
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
NCT01737762
Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation
NCT01705860
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
NCT01656889
Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
NCT01433159
Using Santyl on Diabetic Foot Ulcers
NCT01408277
Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients
NCT01359735
Study to Determine if Fibrin Affects the Ability of a Wound to Heal
NCT01253135
Wound Edge Changes Following Treatment With Santyl
NCT01197898
Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds
NCT01190865
Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers
NCT01143727
A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers
NCT01143714
Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage
NCT01108523
Santyl vs. Sharp Debridement of Diabetic Foot Wounds
NCT01056198
Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds
NCT00971048
Safety Follow-Up to HP 802-247-09-015
NCT00900029
Dose Finding Study of HP802-247 in Venous Leg Ulcers
NCT00852995
Cumulative Irritation Potential of 828 Ointment
NCT00767455
Contact Sensitization Potential of 828 Ointment
NCT00767676
Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on Healing
NCT00713349
Effect of Collagenase on Healing and Scarring
NCT00651820
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
NCT00645164
OASIS Wound Matrix (Oasis) Mechanism of Action
NCT00570141
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 5 |
| Phase 3 | 2 |
| Phase 4 | 9 |
Therapeutic Areas
How the Healthpoint archive is shaped
25 indexed studies, none listed as recruiting (0% open); 22 completed (88%).
Phase mix: 11 late (III/IV) vs 11 early (I/II) (balanced across stages).
Top condition: Follow up to Acute Wound Scar Study (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Healthpoint: archived-pipeline peers nationwide
Peers matched on 25 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Healthpoint sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 25 archived trials
- Arcus Biosciences · 25 trials · 12% recruiting
- Arcutis Biotherapeutics · 25 trials · 8% recruiting
- Ardelyx · 25 trials · 12% recruiting
- Drexel University College of Medicine · 25 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Healthpoint page
25 registered trials is a research-attention snapshot, not an endorsement of Healthpoint or any single study.
- None of Healthpoint's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Follow up to Acute Wound Scar Study is the condition Healthpoint studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Follow up to Acute Wound Scar Study trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Healthpoint pipeline card: 25 registered trials from official public datasets.Report a data error.